Aptinyx

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptinyx and other ETFs, options, and stocks.

About APTX

Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program.

CEO

Andrew Kidd

CEOAndrew Kidd

Employees

Employees40

Headquarters

Evanston, Illinois

HeadquartersEvanston, Illinois

Founded

2015

Founded2015

Employees

Employees40

APTX Key Statistics

Market cap

33.49M

Market cap33.49M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

239.57K

Average volume239.57K

High today

—

High today—

Low today

—

Low today—

Open price

$0.4251

Open price$0.4251

Volume

0.00

Volume0.00

52 Week high

$3.76

52 Week high$3.76

52 Week low

$0.20

52 Week low$0.20

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

APTX Earnings

-$0.35

-$0.23

-$0.12

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 22, After Hours

ActualExpected Mar 22, After Hours